"Florida Cancer Specialists provides the most advanced cancer treatment options available, close to home, and personalized for each patient’s unique needs. At our Tallahassee Cancer Center, we provide treatment for all forms of cancers and blood disorders, including laboratory, pharmacy, gynecologic oncology, nutritional counseling and care management. Clinical trials and Dignicap® available."

During the past decade, Florida Cancer Research Institute conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 35 clinical trials were completed, i.e. on average, 159.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 15 clinical trials were completed. i.e. 375% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Cancer Research Institute" #1 sponsor was "Novartis Pharmaceuticals" with 8 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Genentech, Inc." with 6 trials sponsored, "Pfizer" with 4 trials sponsored and "Puma Biotechnology, Inc." with 4 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Cancer Research Institute" #1 collaborator was "Genentech, Inc." with 5 trials as a collaborator, "CIMYM BioSciences" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Sellas Life Sciences Group" with 2 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Florida Cancer Research Institute" are "Breast Cancer" (26 trials), "Metastatic Breast Cancer" (9 trials), "Advanced Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials) and "HER2 Positive Breast Cancer" (2 trials). Many other conditions were trialed in "Florida Cancer Research Institute" in a lesser frequency.

Most popular intervention types in "Florida Cancer Research Institute" are "Drug" (53 trials), "Biological" (5 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (12 trials), "Placebo" (10 trials), "Trastuzumab" (9 trials), "Docetaxel" (6 trials) and "Cyclophosphamide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Florida Cancer Research Institute" are 34 trials for "All" genders, 20 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Florida Cancer Research Institute". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Florida Cancer Research Institute, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Cancer Research Institute, 4 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Florida Cancer Research Institute has several departments that took part in Clinical trials: "Florida Cancer Specialists" - 8 trials, "Florida Cancer Specialists South" - 83 trials, "Florida Cancer Specialists North" - 67 trials, "Florida Cancer Institute" - 34 trials, "Florida Cancer Specialist, North Region" - 34 trials, "Florida Cancer Specialists Panhandle" - 30 trials, "Cancer & Blood Disease Center" - 19 trials, "Florida Cancer Center - Palatka" - 17 trials, "Florida Cancer Institute - New Hope" - 14 trials, "SCRI Florida Cancer Specialists PAN" - 9 trials